Sorrento Therapeutics (NASDAQ:SRNE) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Trading Down 12.8 % Shares of NASDAQ SRNE opened at $0.01 on Friday. Sorrento Therapeutics has a 12 month low of $0.00 and […]
More Stories
US Annual Inflation Rate Stabilizes in July, Slowing to 3.4 Percent
By Andrew Moran Stabilizing energy prices have helped cool off inflation pressures for the second straight month, new government data...
State Department Launches Birth Tourism Prevention Task Force
By Troy Myers The Department of State on Wednesday announced the existence of a task force that has already revoked...
Todd Blanche Sworn In as Attorney General
By Kimberly Hayek Todd Blanche, President Donald Trump’s former personal lawyer, was sworn in Monday as U.S. attorney general and...
16,000 Arrests Made as Part of Operation to Make Washington Safe
By Naveen Athrappully More than 16,000 individuals have been arrested in Washington since the launch of the Make D.C. Safe...
Commercial Chapter 11 Bankruptcy Filings Decrease Annually
By Naveen Athrappully There were 666 commercial Chapter 11 bankruptcy filings made in the United States in July, a 27...
Syrian Court Sentences Ex-President Bashar Assad to Death
By Tom Ozimek A Syrian court sentenced ousted leader Bashar al-Assad to death on Tuesday, convicting him of crimes committed...